R&D News
Most Popular R&D Story
Pfizer dumping heart disease focus in R&D restructuring
In a major reorganization of its research efforts, Pfizer is abandoning its early-stage work in heart disease, leaving a field that has produced some of its biggest blockbusters. In addition, the... Read more...
Latest Headlines
- October 20, 2009
- May 11, 2009
- April 13, 2009
- April 7, 2009
- March 24, 2009
- March 23, 2009
- January 30, 2009
- November 4, 2008
- September 30, 2008
- September 23, 2008
- June 10, 2008
- April 8, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
